These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29900540)

  • 1. Contemporary prenatal aneuploidy screening practice in Australia: Frequently asked questions in the cell-free DNA era.
    Rieder W; White S; McGillivray G; Hui L
    Aust N Z J Obstet Gynaecol; 2018 Aug; 58(4):397-403. PubMed ID: 29900540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.
    McLennan A; Palma-Dias R; da Silva Costa F; Meagher S; Nisbet DL; Scott F
    Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):22-8. PubMed ID: 26817523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-free DNA screening for trisomies 21, 18, and 13 in pregnancies at low and high risk for aneuploidy with genetic confirmation.
    Dar P; Jacobsson B; MacPherson C; Egbert M; Malone F; Wapner RJ; Roman AS; Khalil A; Faro R; Madankumar R; Edwards L; Haeri S; Silver R; Vohra N; Hyett J; Clunie G; Demko Z; Martin K; Rabinowitz M; Flood K; Carlsson Y; Doulaveris G; Malone C; Hallingstrom M; Klugman S; Clifton R; Kao C; Hakonarson H; Norton ME
    Am J Obstet Gynecol; 2022 Aug; 227(2):259.e1-259.e14. PubMed ID: 35085538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practice.
    Salomon LJ; Alfirevic Z; Audibert F; Kagan KO; Paladini D; Yeo G; Raine-Fenning N;
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):815-816. PubMed ID: 28573775
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.
    Langlois S; Duncan A; ;
    J Obstet Gynaecol Can; 2011 Sep; 33(9):955-960. PubMed ID: 21923994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal fraction-based risk algorithm for non-invasive prenatal testing: screening for trisomies 13 and 18 and triploidy in women with low cell-free fetal DNA.
    McKanna T; Ryan A; Krinshpun S; Kareht S; Marchand K; Grabarits C; Ali M; McElheny A; Gardiner K; LeChien K; Hsu M; Saltzman D; Stosic M; Martin K; Benn P
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):73-79. PubMed ID: 30014528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening.
    Wagner AJ; Mitchell ME; Tomita-Mitchell A
    Clin Perinatol; 2014 Dec; 41(4):957-66. PubMed ID: 25459783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA sequencing versus standard prenatal aneuploidy screening.
    Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
    N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Validation of Non-Invasive Prenatal Testing for Fetal Common Aneuploidies in 1,055 Korean Pregnant Women: a Single Center Experience.
    Lee DE; Kim H; Park J; Yun T; Park DY; Kim M; Ryu HM
    J Korean Med Sci; 2019 Jun; 34(24):e172. PubMed ID: 31222985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of fetal chromosomal aneuploidy diseases using noninvasive prenatal testing in twin pregnancies.
    Yu W; Lv Y; Yin S; Liu H; Li X; Liang B; Kong L; Liu C
    Expert Rev Mol Diagn; 2019 Feb; 19(2):189-196. PubMed ID: 30582381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined first trimester screening and cell-free fetal DNA - “next generation screening”].
    Kagan KO; Eiben B; Kozlowski P
    Ultraschall Med; 2014 Jun; 35(3):229-36. PubMed ID: 24764214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive prenatal testing.
    Harraway J
    Aust Fam Physician; 2017 Oct; 46(10):735-739. PubMed ID: 29036772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
    Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence of cell-free DNA noninvasive prenatal screens to ACMG recommendations.
    Skotko BG; Allyse MA; Bajaj K; Best RG; Klugman S; Leach M; Meredith S; Michie M; Stoll K; Gregg AR
    Genet Med; 2019 Oct; 21(10):2285-2292. PubMed ID: 30940924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective chromosome analysis of 3429 amniocentesis samples in China using copy number variation sequencing.
    Wang J; Chen L; Zhou C; Wang L; Xie H; Xiao Y; Zhu H; Hu T; Zhang Z; Zhu Q; Liu Z; Liu S; Wang H; Xu M; Ren Z; Yu F; Cram DS; Liu H
    Am J Obstet Gynecol; 2018 Sep; 219(3):287.e1-287.e18. PubMed ID: 29852155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of nuchal translucency ultrasound in identifying rare chromosomal abnormalities not detectable by cell-free DNA screening.
    Berger VK; Norton ME; Sparks TN; Flessel M; Baer RJ; Currier RJ
    Prenat Diagn; 2020 Jan; 40(2):185-190. PubMed ID: 31652356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA.
    Porreco RP; Garite TJ; Maurel K; Marusiak B; ; Ehrich M; van den Boom D; Deciu C; Bombard A
    Am J Obstet Gynecol; 2014 Oct; 211(4):365.e1-12. PubMed ID: 24657131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contingent prenatal screening for frequent aneuploidies with cell-free fetal DNA analysis.
    Torres Aguilar MR; Carrasco Salas P; Santos Rosa C; Bueno Rodríguez G; Martínez-Bonet E; Carreto Alba P; León-Justel A; Granell Escobar MR
    Taiwan J Obstet Gynecol; 2021 Jul; 60(4):745-751. PubMed ID: 34247818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.